Table 4 Worst non-haematological drug-related toxicity per patients (all cycles)

From: A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer

Treatment arm

Number of patients

 

Carboplatin arm

Paclitaxel arm

Triplet arm

CTCAE grade Toxicity

1

2

3

1

2

3

1

2

3

Fatigue

4

5

3

5

7

3

5

Pain

6

4

2

2

8

2

1

5

0

Sensory neuropathy

6

1

8

1

1

5

3

Alopecia

2

12

1

7

Nausea

4

5

4

2

3

4

Pain – headache

1

5

1

3

1

1

4

QTc prolongation

3

7

2

2

1

Vomiting

3

2

1

3

3

2

Hypertension

3

2

1

2

3

1

Constipation

4

1

4

2

Diarrhoea

2

1

 

3

1

1

2

3

Pyrexia

3

5

2

1

Flushing

3

1

1

2

1

Hypotension

1

1

3

1

2

Itching

3

1

4

Anorexia

1

1

4

1

Infection

1

1

2

2

1

Myalgia

1

3

2

1

Neurological: muzzy head

2

2

1

Oedema

2

1

1

1

Perianal itching

3

1

1

Rash

1

1

1

2

Stomatitis

1

1

1

2

Tachycardia

1

2

2

Agitation

2

1

1

Cough

1

1

1

Motor neuropathy

1

1

1

Allergy

1a

1

1

Ataxia

1

1

Dysphasia

1

1

Dehydration

1

Incontinence

1

Sepsis

1

  1. Abbreviation: CTCAE=common terminology criteria for adverse events.
  2. aGrade 4 toxicity.